The Future of Psychedelic Medicine
Our Story
Find out what inspires us to support mental health disorders.
Our Mission
Supporting innovative therapies to help humans thrive.
Our Team
Multi-Disciplinary Collaboration
creating positive experiences and outcomes.
Mission
Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.
CORE PILLARS
HAVN Labs
- Havn Labs will support innovative therapies addressing human health through the development of methods for standardization and the extraction of quality-controlled compounds derived from plants and fungi.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
350 Million
People globally are affected by a form of depression.
1 Trillion
Dollars lost annually in global workforce productivity due to depression and anxiety.
0
Formulas standardized across clinical studies of psychedelic compounds.
Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
Havn Life Signs Exclusive Supply Agreement With ATMA Journey Centers
Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica Vancouver, BC – Havn Life Sciences Inc. (CSE: …
Havn Life Develops New Method for Rapid Psilocybin Testing
Havn Life has completed its analytical work under its Health Canada Section 56 exemption Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: …
Havn Labs Jamaica Facility Now Fully Operational
The Company has started production of its first grow with local partner Hypha Wellness. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) …